• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病患者中等强度和高强度运动训练的随机对照试验:对体能和运动心血管反应的影响。

Randomized Controlled Trial of Moderate- and High-Intensity Exercise Training in Patients With Hypertrophic Cardiomyopathy: Effects on Fitness and Cardiovascular Response to Exercise.

机构信息

Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Dallas Dallas TX USA.

University of Texas Southwestern Medical Center Dallas TX USA.

出版信息

J Am Heart Assoc. 2023 Oct 17;12(20):e031399. doi: 10.1161/JAHA.123.031399. Epub 2023 Oct 13.

DOI:10.1161/JAHA.123.031399
PMID:37830338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10757533/
Abstract

Background Moderate intensity exercise training (MIT) is safe and effective for patients with hypertrophic cardiomyopathy, yet the efficacy of high intensity training (HIT) remains unknown. This study aimed to compare the efficacy of HIT compared with MIT in patients with hypertrophic cardiomyopathy. Methods and Results Patients with hypertrophic cardiomyopathy were randomized to either 5 months of MIT, or 1 month of MIT followed by 4 months of progressive HIT. Peak oxygen uptake (V˙O; Douglas bags), cardiac output (acetylene rebreathing), and arteriovenous oxygen difference (Fick equation) were measured before and after training. Left ventricular outflow gradient and volumes were measured by echocardiography. Fifteen patients completed training (MIT, n=8, age 52±7 years; HIT, n=7, age 42±8 years). Both HIT and MIT improved peak V˙O by 1.3 mL/kg per min (=0.009). HIT (+1.5 mL/kg per min) had a slightly greater effect than MIT (+1.1 mL/kg per min) but with no statistical difference (group×exercise =0.628). A greater augmentation of arteriovenous oxygen difference occurred with exercise (Δ1.6 mL/100 mL =0.005). HIT increased left ventricular end-diastolic volume (+17 mL, group×exercise =0.015) compared with MIT. No serious arrhythmias or adverse cardiac events occurred. Conclusions This randomized trial of exercise training in patients with hypertrophic cardiomyopathy demonstrated that both HIT and MIT improved fitness without clear superiority of either. Although the study was underpowered for safety outcomes, no serious adverse events occurred. Exercise training resulted in salutary peripheral and cardiac adaptations. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT03335332.

摘要

背景

中等强度运动训练(MIT)对肥厚型心肌病患者是安全且有效的,但高强度训练(HIT)的疗效仍不清楚。本研究旨在比较 HIT 与 MIT 在肥厚型心肌病患者中的疗效。

方法和结果

肥厚型心肌病患者被随机分为 MIT 组(5 个月)或 MIT 组(1 个月)后进行 4 个月的渐进性 HIT 组。训练前后分别用 Douglas 袋测量峰值摄氧量(V˙O)、心输出量(乙炔再呼吸)和动静脉血氧差(Fick 方程),用超声心动图测量左心室流出道梯度和容积。15 例患者完成了训练(MIT 组,n=8,年龄 52±7 岁;HIT 组,n=7,年龄 42±8 岁)。HIT 和 MIT 均使峰值 V˙O 提高了 1.3 mL/kg/min(=0.009)。HIT(增加 1.5 mL/kg/min)的效果略大于 MIT(增加 1.1 mL/kg/min),但无统计学差异(组×运动=0.628)。运动时动静脉血氧差增加更大(Δ1.6 mL/100 mL =0.005)。HIT 使左心室舒张末期容积增加(+17 mL,组×运动=0.015),而 MIT 则没有。没有发生严重心律失常或不良心脏事件。

结论

本研究对肥厚型心肌病患者进行了运动训练的随机试验,结果表明,HIT 和 MIT 均能提高体能,且无明显优势。尽管该研究在安全性方面的效力不足,但未发生严重不良事件。运动训练导致有益的外周和心脏适应性改变。

注册网址

https://www.clinicaltrials.gov;独特标识符:NCT03335332。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33d7/10757533/70e4a247d5e7/JAH3-12-e031399-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33d7/10757533/aeeb2d2f67a0/JAH3-12-e031399-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33d7/10757533/7aaad19979b8/JAH3-12-e031399-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33d7/10757533/76847f6d56ea/JAH3-12-e031399-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33d7/10757533/70e4a247d5e7/JAH3-12-e031399-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33d7/10757533/aeeb2d2f67a0/JAH3-12-e031399-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33d7/10757533/7aaad19979b8/JAH3-12-e031399-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33d7/10757533/76847f6d56ea/JAH3-12-e031399-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33d7/10757533/70e4a247d5e7/JAH3-12-e031399-g004.jpg

相似文献

1
Randomized Controlled Trial of Moderate- and High-Intensity Exercise Training in Patients With Hypertrophic Cardiomyopathy: Effects on Fitness and Cardiovascular Response to Exercise.肥厚型心肌病患者中等强度和高强度运动训练的随机对照试验:对体能和运动心血管反应的影响。
J Am Heart Assoc. 2023 Oct 17;12(20):e031399. doi: 10.1161/JAHA.123.031399. Epub 2023 Oct 13.
2
Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.中等强度运动训练对肥厚型心肌病患者峰值摄氧量的影响:一项随机临床试验。
JAMA. 2017 Apr 4;317(13):1349-1357. doi: 10.1001/jama.2017.2503.
3
Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients in Scandinavia.高强度间歇训练对斯堪的纳维亚地区心脏移植初治患者的影响。
Circulation. 2019 May 7;139(19):2198-2211. doi: 10.1161/CIRCULATIONAHA.118.036747.
4
Impact of continuous vs. interval training on oxygen extraction and cardiac function during exercise in type 2 diabetes mellitus.2 型糖尿病患者运动时连续训练与间歇训练对氧摄取和心功能的影响。
Eur J Appl Physiol. 2022 Apr;122(4):875-887. doi: 10.1007/s00421-022-04884-9. Epub 2022 Jan 17.
5
Affective Responses to Repeated Sessions of High-Intensity Interval Training.对重复进行高强度间歇训练的情感反应。
Med Sci Sports Exerc. 2015 Dec;47(12):2604-11. doi: 10.1249/MSS.0000000000000721.
6
Exercise Intensity Matters in Chronic Nonspecific Low Back Pain Rehabilitation.运动强度在慢性非特异性下腰痛康复中很重要。
Med Sci Sports Exerc. 2019 Dec;51(12):2434-2442. doi: 10.1249/MSS.0000000000002078.
7
Cardiac output response and peripheral oxygen extraction during exercise among symptomatic hypertrophic cardiomyopathy patients with and without left ventricular outflow tract obstruction.有和无左心室流出道梗阻的症状性肥厚型心肌病患者在运动期间的心输出量反应和外周氧提取。
Heart. 2014 Apr;100(8):639-46. doi: 10.1136/heartjnl-2013-304914. Epub 2014 Jan 21.
8
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.马卡丹特治疗有症状梗阻性肥厚型心肌病(EXPLORER-HCM)的随机、双盲、安慰剂对照、3 期临床试验
Lancet. 2020 Sep 12;396(10253):759-769. doi: 10.1016/S0140-6736(20)31792-X. Epub 2020 Aug 29.
9
Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training program in a cardiac rehabilitation center.肥厚型心肌病有症状患者运动训练的疗效:心脏康复中心结构化运动训练计划的结果。
Eur J Prev Cardiol. 2015 Jan;22(1):13-9. doi: 10.1177/2047487313501277. Epub 2013 Aug 8.
10
High-intensity interval training in cardiac rehabilitation: a multi-centre randomized controlled trial.高强度间歇训练在心脏康复中的应用:一项多中心随机对照试验。
Eur J Prev Cardiol. 2023 Jul 12;30(9):745-755. doi: 10.1093/eurjpc/zwad039.

引用本文的文献

1
Comparative effects of moderate and high-intensity training on immune activation in myocarditis: a review of preclinical and clinical evidence.中度和高强度训练对心肌炎免疫激活的比较影响:临床前和临床证据综述
Front Pharmacol. 2025 Aug 20;16:1643056. doi: 10.3389/fphar.2025.1643056. eCollection 2025.
2
Unplanned Readmissions in Pediatric Cardiac Disease: Impacts of Social Determinants of Health.小儿心脏病的非计划再入院:健康的社会决定因素的影响
Pediatr Cardiol. 2025 May 17. doi: 10.1007/s00246-025-03883-9.
3
High-Intensity Training on Patients with Hypertrophic Cardiomyopathy: A Systematic Review.

本文引用的文献

1
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者的剧烈运动。
JAMA Cardiol. 2023 Jun 1;8(6):595-605. doi: 10.1001/jamacardio.2023.1042.
2
Limits to submaximal and maximal exercise in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者的亚极限和极限运动的限制。
J Appl Physiol (1985). 2022 Oct 1;133(4):787-797. doi: 10.1152/japplphysiol.00566.2021. Epub 2022 Aug 11.
3
Validation of the Kansas City Cardiomyopathy Questionnaire in Symptomatic Obstructive Hypertrophic Cardiomyopathy.
肥厚型心肌病患者的高强度训练:一项系统评价
Egypt Heart J. 2025 May 15;77(1):45. doi: 10.1186/s43044-025-00642-2.
4
Feasibility of an Individualized Exercise Training Program for Children with Hypertrophic Cardiomyopathy.肥厚型心肌病患儿个体化运动训练计划的可行性
Pediatr Cardiol. 2025 Apr 15. doi: 10.1007/s00246-025-03843-3.
5
Exercise across the cardiovascular continuum: expanding perspectives on its key role in contemporary clinical practice.贯穿心血管连续统一体的运动:拓展其在当代临床实践中关键作用的视角
Porto Biomed J. 2025 Apr 1;10(2):e290. doi: 10.1097/j.pbj.0000000000000290. eCollection 2025 Mar-Apr.
6
High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial.肥厚型心肌病患者的高强度运动计划:一项随机试验。
Eur Heart J. 2025 May 14;46(19):1803-1815. doi: 10.1093/eurheartj/ehae919.
7
Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.《2024年墨西哥肥厚型心肌病诊断与治疗指南》
Arch Cardiol Mex. 2024;94(Supl 4):1-75. doi: 10.24875/ACM.M25000098.
8
The design and rationale of the cardiac REHABilitation to improve metabolic health in Hypertrophic CardioMyopathy (REHAB-HCM) Study.肥厚型心肌病心脏康复改善代谢健康(REHAB-HCM)研究的设计与原理
Am Heart J Plus. 2025 Jan 10;50:100501. doi: 10.1016/j.ahjo.2025.100501. eCollection 2025 Feb.
9
Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy.奥地利肥厚型心肌病诊断与管理共识声明
Wien Klin Wochenschr. 2024 Oct;136(Suppl 15):571-597. doi: 10.1007/s00508-024-02442-1. Epub 2024 Oct 1.
10
Exercise Alleviates Cardiovascular Diseases by Improving Mitochondrial Homeostasis.运动通过改善线粒体稳态缓解心血管疾病。
J Am Heart Assoc. 2024 Oct;13(19):e036555. doi: 10.1161/JAHA.124.036555. Epub 2024 Sep 18.
堪萨斯城心肌病问卷在有症状梗阻性肥厚型心肌病中的验证。
JACC Heart Fail. 2022 Aug;10(8):531-539. doi: 10.1016/j.jchf.2022.03.002. Epub 2022 May 4.
4
Exercise training during childhood and adolescence is associated with favorable diastolic function in hypertrophic cardiomyopathy.儿童和青少年时期的运动训练与肥厚型心肌病的有利舒张功能有关。
Int J Cardiol. 2022 Oct 1;364:65-71. doi: 10.1016/j.ijcard.2022.06.042. Epub 2022 Jun 15.
5
Randomized Trial of Metoprolol in Patients With Obstructive Hypertrophic Cardiomyopathy.随机试验米索洛尔治疗梗阻性肥厚型心肌病患者。
J Am Coll Cardiol. 2021 Dec 21;78(25):2505-2517. doi: 10.1016/j.jacc.2021.07.065.
6
Exercise-Induced Cardiovascular Adaptations and Approach to Exercise and Cardiovascular Disease: JACC State-of-the-Art Review.运动引起的心血管适应性及运动与心血管疾病的处理:JACC 最新观点综述。
J Am Coll Cardiol. 2021 Oct 5;78(14):1453-1470. doi: 10.1016/j.jacc.2021.08.003.
7
Applying Shared Decision Making to Sports Participation for a Patient With Hypertrophic Cardiomyopathy.将共同决策应用于肥厚型心肌病患者的运动参与
JACC Case Rep. 2020 Nov 20;3(1):6-9. doi: 10.1016/j.jaccas.2020.11.005. eCollection 2021 Jan.
8
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 年美国心脏病学会/美国心脏协会肥厚型心肌病诊断和治疗指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南联合委员会的报告。
Circulation. 2020 Dec 22;142(25):e533-e557. doi: 10.1161/CIR.0000000000000938. Epub 2020 Nov 20.
9
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.马卡丹特治疗有症状梗阻性肥厚型心肌病(EXPLORER-HCM)的随机、双盲、安慰剂对照、3 期临床试验
Lancet. 2020 Sep 12;396(10253):759-769. doi: 10.1016/S0140-6736(20)31792-X. Epub 2020 Aug 29.
10
Noninvasive Assessment of Cardiac Output: Accuracy and Precision of the Closed-Circuit Acetylene Rebreathing Technique for Cardiac Output Measurement.无创心输出量评估:乙炔再呼吸技术测量心输出量的准确性和精密度。
J Am Heart Assoc. 2020 Sep;9(17):e015794. doi: 10.1161/JAHA.120.015794. Epub 2020 Aug 27.